Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GenSci094 vs recFSH for Ovarian Stimulation in Chinese ART Patients
NCT06091436Phase 3Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Mar 2023
- Primary completion
- Dec 2023
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of corifollitropin alfa in infertility (2 arms), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd. Primary endpoint: Mean Number of Oocytes Retrieved. Started Mar 2023; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06091436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06091436.